A multicenter phase II study of istiratumab (MM-141) plus nab-paclitaxel (A) and gemcitabine (G) in metastatic pancreatic cancer (MPC) von Ko, Andrew H., Murray, James, Horgan, Kerry E, Dauer, Julia, Curley, Michael, Baum, Jason, Louis, Chrystal Ursula, Lugovskoy, Alexey

Volltext

Abstract P3-11-03: A randomized, phase 2 trial of preoperative MM-121 with paclitaxel in triple negative (TN) and hormone receptor (HR) positive, HER2-negative breast cancer von Holmes, Frankie A, McIntyre, Kristi J, Krop, Ian E, Osborne, Cynthia R, Smith II, John W, Modiano, Manuel R, Gupta, Manish, Downey, Leona B, Nanda, Rita, Saleh, Mansoor N, Young, Jonathan R, Horgan, Kerry E, Kubasek, William, MacBeath, Gavin, Danso, Michael A, O'Shaughnessy, Joyce A

Volltext

Phase II Study of Gemcitabine and Oxaliplatin in Combination With Bevacizumab in Patients With Advanced Hepatocellular Carcinoma von ZHU, Andrew X, BLASZKOWSKY, Lawrence S, STUART, Keith, RYAN, David P, CLARK, Jeffrey W, MUZIKANSKY, Alona, HORGAN, Kerry, SHEEHAN, Susan, HALE, Kelly E, ENZINGER, Peter C, BHARGAVA, Pankaj

Volltext

Scrubbing the Hub, How Long Is Enough? von Alonso, Priscila Badia, Andersen, Heidi, Haslam, David, Flesch, Laura, Kramer, Kathi, Zimmerman, Emily, Ruehlmann, Kristen, Demmel, Kathleen Marie, Sellers, Ashley, Stevenson, Julie, Kohler, Kerry, Fryer, Chelsea, Chiller, Taylor, Trendler, Hannah, Horgan, Kimberly, Simpson, Lauren, Davies, Stella M., Dandoy, Christopher E

Volltext